+49.5%
ILMN vs GSK
+0.3%
+49.2%
-29.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.5% | -0.2% | +2.6% | +2.4% |
| 7D | -9.7% | +1.7% | -11.3% | -9.2% |
| 30D | -20.4% | +7.0% | -27.4% | -20.4% |
| 3M | +10.0% | -2.7% | +12.7% | +11.0% |
| 6M | +49.5% | +1.4% | +48.1% | +49.4% |
| All | +49.5% | +0.3% | +49.2% | +49.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling